Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis
Authors:
- Hugh McA. TaggartHTHugh McA. Taggart
- Deborah Applebaum-BowdenDADeborah Applebaum-Bowden
- John J. AlbersJAJohn J. Albers
- William R. HazzardWHWilliam R. Hazzard
- 1 November 1982
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 31 (11) , 1147-1152
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Changes in plasma high-density lipoprotein cholesterol concentration after weight reduction in grossly obese subjects.BMJ, 1980
- Estrogen Use in Postmenopausal Women — Costs, Risks, and BenefitsNew England Journal of Medicine, 1980
- Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in manAtherosclerosis, 1980
- Aging, Natural Death, and the Compression of MorbidityNew England Journal of Medicine, 1980
- High density lipoproteins during hypolipidemic therapyAtherosclerosis, 1980
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- Effects of Dietary Polyunsaturated and Saturated Fat on the Properties of High Density Lipoproteins and the Metabolism of Apolipoprotein A-IJournal of Clinical Investigation, 1978
- Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of manAtherosclerosis, 1978
- High Density Lipoprotein Metabolism in ManJournal of Clinical Investigation, 1977
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977